One Bad Apple

A unique virus and the worm it infects turn up in an orchard outside of Paris.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ANDRZEJ KRAUZE

The nematode Caenorhabditis elegans is the workhorse of many developmental biology labs. The model organism is simple to grow, its genome is sequenced and well annotated, the developmental history of its 959 somatic cells in the adult hermaphrodite is mapped out, and it’s relatively easy to create genetic mutants. In 2005, three separate research groups showed that C. elegans could protect itself from viral attack using RNA interference (RNAi), but no natural virus capable of infecting the species had ever been described. This raised a question: If the nematode does not get infected by viruses, why does it have innate antiviral defenses?

Marie-Anne Félix, of the Institut Jacques Monod, found the answer in an unlikely place—an orchard in Orsay, a southwestern suburb of Paris. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Richard P. Grant

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development